Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -805.93x is 23% above its 5-year average of -1042.29x, near the high end of its 5-year range (-6387.69x–240.35x).
As of the fiscal period ended Friday, December 31, 2021. 77.91% above its 12-month average of -3648.12x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2021 (2021-12-31): -805.93x.
INTEREST COVERAGE RATIO
-805.93x
INTEREST COVERAGE RATIO AVG TTM
-3648.12x
INTEREST COVERAGE RATIO AVG 3Y
-1307.58x
INTEREST COVERAGE RATIO AVG 5Y
-1042.29x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+77.91%
CURRENT VS 3Y AVG
+38.37%
CURRENT VS 5Y AVG
+22.68%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.13x
median of 332 covered companies
CURRENT VS SECTOR MEDIAN
-19390.35%
vs the sector median at left
Arvinas, Inc.
Market Cap
$483.26M
Interest Coverage Ratio
-805.93x
TTM Avg
-3648.12x
3Y Avg
-1307.58x
5Y Avg
-1042.29x
Market Cap
$484.56M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$488.09M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$477.61M
Interest Coverage Ratio
-1.04x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$470.12M
Interest Coverage Ratio
4.74x
TTM Avg
9.15x
3Y Avg
25.82x
5Y Avg
26.16x
Market Cap
$465.02M
Interest Coverage Ratio
30.36x
TTM Avg
30.37x
3Y Avg
18.36x
5Y Avg
29.15x
Market Cap
$458.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$452.63M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arvinas, Inc. (ARVN) | $483.26M | -805.93x | -3648.12x | -1307.58x | -1042.29x |
| Contineum Therapeutics, Inc. (CTNM)vs › | $484.56M | N/A | N/A | N/A | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $488.09M | N/A | N/A | N/A | N/A |
| Cerus Corporation (CERS)vs › | $477.61M | -1.04x | N/A | N/A | N/A |
| Evolus, Inc. (EOLS)vs › | $491.93M | -1.91x | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $470.12M | 4.74x | 9.15x | 25.82x | 26.16x |
| Kamada Ltd. (KMDA)vs › | $465.02M | 30.36x | 30.37x | 18.36x | 29.15x |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $458.01M | N/A | N/A | N/A | N/A |
| Assembly Biosciences, Inc. (ASMB)vs › | $452.63M | N/A | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $514.16M | -17.61x | 2.56x | 1.47x | 1.63x |
Interest Coverage
-805.9x
Debt/Equity
0.01
Current Ratio
7.91
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-12-31 | -805.93x |
| 2021-09-30 | -5821.54x |
| 2021-06-30 | -6387.69x |
| 2021-03-31 | -2566.15x |
| 2020-12-31 | -2659.29x |
| 2020-09-30 | -1953.73x |
| 2020-06-30 | -1629.78x |
| 2020-03-31 | -1440.74x |
| 2019-12-31 | -1402.46x |
| 2019-09-30 | 240.35x |
| 2019-06-30 | -808.89x |
| 2019-03-31 | -669.03x |
| 2018-12-31 | -687.76x |
| 2018-09-30 | -1146.35x |
| 2018-06-30 | -862.89x |
| 2018-03-31 | -401.36x |
| 2017-12-31 | -463.41x |
| 2017-09-30 | -524.70x |
| 2017-06-30 | -518.36x |
| 2017-03-31 | -460.67x |
